Laurel Wealth Advisors LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLU and the CUSIP is 81369Y886. A total of 1,056 filers reported holding SELECT SECTOR SPDR TR in Q1 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Laurel Wealth Advisors LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$1,256,750
-8.7%
21,327
+1.4%
0.27%
-3.6%
Q2 2023$1,376,350
-6.7%
21,033
-3.5%
0.28%
-11.5%
Q1 2023$1,475,195
+7.5%
21,794
+11.9%
0.31%
+0.6%
Q4 2022$1,372,797
+11.7%
19,473
+3.8%
0.31%
+1.3%
Q3 2022$1,229,000
-0.8%
18,764
+6.2%
0.31%
+2.0%
Q2 2022$1,239,000
-6.8%
17,665
-1.0%
0.30%
+7.5%
Q1 2022$1,329,000
+8.0%
17,842
+3.9%
0.28%
+10.7%
Q4 2021$1,230,000
+13.6%
17,177
+1.3%
0.25%
+5.4%
Q3 2021$1,083,000
-1.8%
16,952
-2.8%
0.24%
+0.4%
Q2 2021$1,103,000
+7.5%
17,442
+8.8%
0.24%
-4.4%
Q1 2021$1,026,000
+0.5%
16,026
-1.5%
0.25%
-6.0%
Q4 2020$1,021,000
+17.8%
16,276
+11.4%
0.26%
+2.3%
Q3 2020$867,000
+3.8%
14,607
-1.3%
0.26%
-5.5%
Q2 2020$835,000
+4.6%
14,798
+2.7%
0.27%
-8.7%
Q1 2020$798,000
-18.0%
14,405
-4.3%
0.30%
-2.0%
Q4 2019$973,000
+2.1%
15,055
+2.3%
0.31%
-6.1%
Q3 2019$953,000
+16.5%
14,722
+7.4%
0.33%
+13.2%
Q2 2019$818,000
+4.9%
13,714
+2.3%
0.29%
+0.7%
Q1 2019$780,000
+12.1%
13,403
+2.0%
0.29%
+2.1%
Q4 2018$696,00013,1450.28%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q1 2022
NameSharesValueWeighting ↓
Wechter Feldman Wealth Management, Inc. 394,576$25,498,00017.00%
Knighthead Capital Management, LLC 1,000,000$64,620,00013.76%
BEACONLIGHT CAPITAL, LLC 935,400$60,446,00012.77%
Chapwood Capital Investment Management, LLC 194,826$12,590,00012.66%
Florin Court Capital LLP 364,200$23,535,00010.06%
Arrow Investment Advisors, LLC 201,407$13,015,0006.43%
DOW CHEMICAL CO /DE/ 450,212$29,093,0006.40%
LOCKHEED MARTIN INVESTMENT MANAGEMENT CO 1,833,800$118,500,0006.26%
MOULTON WEALTH MANAGEMENT, INC 115,106$7,360,0006.08%
GM Advisory Group, LLC 297,799$19,244,0005.96%
View complete list of SELECT SECTOR SPDR TR shareholders